BE899484A - Nouveaux determinants antigeniques apparentes a l'adenocarcinome et anticorps qui leur sont specifiques. - Google Patents

Nouveaux determinants antigeniques apparentes a l'adenocarcinome et anticorps qui leur sont specifiques.

Info

Publication number
BE899484A
BE899484A BE0/212811A BE212811A BE899484A BE 899484 A BE899484 A BE 899484A BE 0/212811 A BE0/212811 A BE 0/212811A BE 212811 A BE212811 A BE 212811A BE 899484 A BE899484 A BE 899484A
Authority
BE
Belgium
Prior art keywords
adenocarcinoma
specific
antibodies
antigenic determinants
novel antigenic
Prior art date
Application number
BE0/212811A
Other languages
English (en)
Original Assignee
Erba Farmitalia
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Erba Farmitalia filed Critical Erba Farmitalia
Publication of BE899484A publication Critical patent/BE899484A/fr

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57565—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving carcinoembryonic antigen [CEA]
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/5753—Immunoassay; Biospecific binding assay; Materials therefor for cancer of the stomach or small intestine

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Food Science & Technology (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

Procédé se pretant au diagnostic d'un adénocarcinome humain par détermination de la matière antigénique apparentée à l'adénocarcinome dans un échantillon prélevé sur un patient humain, suivant lequel on utilise (a) un anticorps anti-K ou (b) un anticorps anti-p pour déterminer la matière dans l'échantillon ayant respectivement (a') exclusivement les déterminants antigènes K spécifiques des adénocarcinomes ou (b') les déterminants antigènes p associés aux déterminants K sur les adénocarcinomes.
BE0/212811A 1983-06-23 1984-04-20 Nouveaux determinants antigeniques apparentes a l'adenocarcinome et anticorps qui leur sont specifiques. BE899484A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB838317022A GB8317022D0 (en) 1983-06-23 1983-06-23 Adenocarcinoma related new antigenic determinants

Publications (1)

Publication Number Publication Date
BE899484A true BE899484A (fr) 1984-10-22

Family

ID=10544654

Family Applications (1)

Application Number Title Priority Date Filing Date
BE0/212811A BE899484A (fr) 1983-06-23 1984-04-20 Nouveaux determinants antigeniques apparentes a l'adenocarcinome et anticorps qui leur sont specifiques.

Country Status (13)

Country Link
JP (1) JPS6018765A (fr)
AU (1) AU2017183A (fr)
BE (1) BE899484A (fr)
DE (1) DE3337465A1 (fr)
DK (1) DK476083A (fr)
FI (1) FI833742L (fr)
FR (1) FR2548901A1 (fr)
GB (1) GB8317022D0 (fr)
IT (1) IT1194429B (fr)
NL (1) NL8303571A (fr)
NO (1) NO833756L (fr)
SE (1) SE8305667L (fr)
ZA (1) ZA837673B (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2589630B2 (ja) * 1992-06-12 1997-03-12 ゼニヤ海洋サービス株式会社 砂防ダム用放水装置

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4086217A (en) * 1976-03-03 1978-04-25 Hoffmann-La Roche Inc. Carcinoembryonic antigens
US4145336A (en) * 1976-04-30 1979-03-20 Scripps Clinic And Research Foundation Carcinoembryonic antigen isomer
US4315851A (en) * 1978-12-29 1982-02-16 Kureha Kagaku Kogyo Kabushiki Kaisha Pharmaceutical composition having antitumor activity
US4349528A (en) * 1979-11-21 1982-09-14 The Wistar Institute Monocolonal hybridoma antibody specific for high molecular weight carcinoembryonic antigen
EP0044167A3 (fr) * 1980-07-14 1982-04-21 The Regents Of The University Of California Agent cytotoxique dirigé par un anticorps
EP0072902B1 (fr) * 1981-08-21 1985-04-24 F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft Procédé pour la détermination des antigènes carcinoembryonnaires (CEA) et pour la détermination appropriée de solution d'anticorps
DE3230299A1 (de) * 1982-08-14 1984-02-16 Hoechst Ag, 6230 Frankfurt Carcinoembryonales antigen, verfahren zu seiner isolierung und seine verwendung

Also Published As

Publication number Publication date
FR2548901A1 (fr) 1985-01-18
DE3337465A1 (de) 1985-01-03
ZA837673B (en) 1984-08-29
FI833742A7 (fi) 1984-12-24
IT8323351A0 (it) 1983-10-19
NO833756L (no) 1984-12-27
DK476083D0 (da) 1983-10-14
SE8305667D0 (sv) 1983-10-14
SE8305667L (sv) 1984-12-24
GB8317022D0 (en) 1983-07-27
JPS6018765A (ja) 1985-01-30
AU2017183A (en) 1985-01-03
NL8303571A (nl) 1985-01-16
FI833742A0 (fi) 1983-10-14
IT1194429B (it) 1988-09-22
FI833742L (fi) 1984-12-24
DK476083A (da) 1984-12-24

Similar Documents

Publication Publication Date Title
IL76827A0 (en) Immunoassays for denaturated protein analytes,particularly hb alc,and monoclonal antibodies thereto
AR243931A1 (es) Antigeno purificado,conjunto de reactivos para la deteccion de anticuerpos anti-hiv-2 en un fluido biologico que comprende dichos antigenos,anticuerpos,hibridomas y procedimientos.
CU22615A1 (es) Procedimiento de obtención de anticuerpos monoclonales murinos menos inmunogénicos. anticuerpos monoclonales obtenidos
ATE76301T1 (de) Nachweis aktivierter blutplaettchen mittels antikoerper gegen zelloberflaechenantigene.
WO1996021734A3 (fr) Antigenes p15 et tyrosinase du melanome et leur utilisation dans des procedes diagnostiques et therapeutiques
DK392387D0 (da) Monoklonalt antistrof til diagnostisk anvendelse og fremgangsmaade til fremstilling af et saadan antistof
GB2188941B (en) Monoclonal antibodies recognizing human interleukin-2-receptor
EP0232179A3 (en) Assay for human breast cancer
DE69034254D1 (de) A-pdgf-rezeptor und dessen verwendung
NO175639C (no) Peptid, antistoff oppnådd ved hjelp av peptidet, en fremgangsmåte for immunologisk bestemmelse av intakt prokollagen peptid (type III) og anvendelse av peptidet
FR2563630B1 (fr) Anticorps monoclonaux anticytomegalovirus et procedes pour le diagnostic in vitro des infections par les cytomegalovirus humains et d'une proteine-kinase inductible par les cytomegalovirus et susceptible d'etre reconnue par les susdits anticorps monoclonaux
EP0834567A3 (fr) Composés et méthodes pour le diagnostique et le traitement d'infections à Babesia microti
DE69026875D1 (de) Immunobestimmung von menschlichem osteocalcin, reagenz und satz dafür
BE899484A (fr) Nouveaux determinants antigeniques apparentes a l'adenocarcinome et anticorps qui leur sont specifiques.
FI922666A0 (fi) Diagnostiskt foerfarande.
FR2435040A1 (fr) Composition pour determiner l'immunoglobuline g humaine, procede pour sa preparation et son emploi
EP0293827A3 (fr) Essai pour leishmaniose
SE8205891D0 (sv) Alfa-l-antikropp och sett for framstellning derav
SE9000931D0 (sv) Antikroppar mot proteiner
DE3889945D1 (de) Methoden und Materialien für die HIV-Erkennung und Therapie.
ATE154395T1 (de) Monoklonale antikörper
ATE125306T1 (de) Monoklonale antikörper, die einen unterschied zwischen nativproteinen und proteinen mit einer modifizierten sequenz machen.
RU97114296A (ru) Способ получения диагностической сыворотки
FR2601037B1 (fr) Peptide presentant des proprietes antigeniques isole de la proteine 28 kd de s. mansoni et son procede d'isolement, anticorps monoclonaux reconnaissant au moins un epitope dudit peptide et application de celui-ci dans l'induction de la synthese d'anticorps neutralisants
UA49257A (uk) Спосіб одержання видоспецифічної r-бруцелаовісної аглютинуючої сироватки

Legal Events

Date Code Title Description
RE Patent lapsed

Owner name: FARMITALIA CARLO ERBA

Effective date: 19860430